Iq Eq Fund Management (Ireland) LTD Vertex Pharmaceuticals Inc Transaction History

Iq Eq Fund Management (Ireland) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $243,565 - $307,467	-1,376 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$225.48 - $295.8 $310,260 - $407,020	1,376 New	1,376 $399,000
Q1 2020 May 05, 2020	SELL	$199.77 - $247.81 $274,883 - $340,986	-1,376 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $63,683 - $85,533	-382 Reduced 21.73%	1,376 $301,000
Q2 2019 Jul 19, 2019	BUY	$164.61 - $190.37 $289,384 - $334,670	1,758 New	1,758 $322,000

1,623

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.